Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy

Withdrawn before enrolling · Not applicable

Conditions studied: Brain and Central Nervous System Tumors

In brief

RATIONALE: Studying samples of blood in the laboratory from patients receiving radiation therapy and chemotherapy may help doctors learn more about the effects of this treatment on cells. It may also help doctors understand how well patients respond to treatment. PURPOSE: This research study is studying biomarkers in blood samples from young patients with newly diagnosed brain tumors undergoing standard radiation therapy and chemotherapy.

Key facts

Study ID
NCT01233479
Run by
Pediatric Brain Tumor Consortium
People needed
0
Starts
2010-05-01
Expected to finish
2017-08-24
Last updated by the study team
2019-04-01

Who can join

Age: 4 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.